Katie N. Hunt, M.D.

  1. Radiologist

Publicaciones

  1. Tao AT, Hruska CB, Conners AL, Hunt KN, Swanson TN, Tran TD, Manduca A, Borges L, Maidment ADA, Lake D, Johnson MP, Carter RE, Rhodes DJ, O'Connor MK. Dose Reduction in Molecular Breast Imaging With a New Image-Processing Algorithm. AJR Am J Roentgenol. 2019 Oct 8; 1-9 Epub 2019 Oct 08
    View PubMed
  2. Hunt KN, Conners AL, Goetz MP, O'Connor MK, Suman V, Kalari K, Weinshilboum R, Wang L, Carter J, McLaughlin S, Aspitia AM, Gray R, Northfelt D, Boughey JC. Comparison of (99m)Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy. AJR Am J Roentgenol. 2019 Oct; 213 (4):932-943 Epub 2019 June 05
    View PubMed
  3. Hunt KN, Hruska CB, Johnson MP, Conners AL, O'Connor MK, Rhodes DJ, Basappa S, Wahner-Roedler D. Molecular Breast Imaging in Patients with Suspicious Calcifications Journal of Breast Imaging. 2019.
  4. Hunt KN, Swanson T, O'Connor MK, Sandhu NP. Detection of multicentric breast cancer using dedicated breast PET. Breast J. 2019 May; 25 (3):512-514 Epub 2019 Apr 06
    View PubMed
  5. Glazebrook KN, Doerge S, Leng S, Drees TA, Hunt KN, Zingula SN, Pruthi S, Geske JR, Carter RE, McCollough CH, Fletcher JG. Ability of Dual-Energy CT to Detect Silicone Gel Breast Implant Rupture and Nodal Silicone Spread. AJR Am J Roentgenol. 2019 Apr; 212 (4):933-942 Epub 2019 Feb 19
    View PubMed
  6. Hruska CB, Hunt KN, Conners AL, Geske JR, Brandt KR, Degnim AC, Vachon CM, O'Connor MK, Rhodes DJ. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study. Breast Cancer Res. 2019 Mar 8; 21 (1):38 Epub 2019 Mar 08
    View PubMed
  7. Samreen N, Hunt KN, Hruska CB, Rhodes DJ. Molecular breast imaging detected invasive lobular carcinoma in dense breasts: A case report. Clin Case Rep. 2019 Mar; 7 (3):442-444 Epub 2019 Jan 28
    View PubMed
  8. Carter RE, Attia ZI, Geske JR, Conners AL, Whaley DH, Hunt KN, O'Connor MK, Rhodes DJ, Hruska CB. Classification of Background Parenchymal Uptake on Molecular Breast Imaging Using a Convolutional Neural Network. JCO Clin Cancer Inform. 2019 Feb; 3:1-11
    View PubMed
  9. Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, Jemal A, Duma N, Haddad TC, Lemaine V, Ghosh K, Hieken TJ, Hunt K, Vachon C, Gross C, Shah ND. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. J Natl Compr Canc Netw. 2018 May; 16 (5):526-534
    View PubMed
  10. Swanson TN, Tran TD, Hruska CB, Solberg CM, Rhodes DJ, Hunt KN, Conners AL, O'Connor MK. Patient Acceptance of Half-dose Vs. Half-time Molecular Breast Imaging. J Med Imaging Radiat Sci. 2018 Mar; 49 (1):39-43 Epub 2017 Sept 13
    View PubMed
  11. Swanson T, Tran TD, Ellingson L, O'Connor MK, Rhodes DJ, Hunt KN, Conners AL, Hruska CB. BEST PRACTICES IN MOLECULAR BREAST IMAGING: A GUIDE FOR TECHNOLOGISTS. J Nucl Med Technol. 2018 Feb 2 Epub 2018 Feb 02
    View PubMed
  12. Illman JE, Terra SB, Clapp AJ, Hunt KN, Fazzio RT, Shah SS, Glazebrook KN. Granulomatous diseases of the breast and axilla: radiological findings with pathological correlation. Insights Imaging. 2018 Feb; 9 (1):59-71 Epub 2018 Feb 05
    View PubMed
  13. O'Connor MK, Tran TD, Swanson TN, Ellingson LR, Hunt KN, Whaley DH. Improved visualization of breast tissue on a dedicated breast PET system through ergonomic redesign of the imaging table. EJNMMI Res. 2017 Dec 19; 7 (1):100
    View PubMed
  14. Yu J, Qin B, Moyer AM, Sinnwell JP, Thompson KJ, Copland JA 3rd, Marlow LA, Miller JL, Yin P, Gao B, Minter-Dykhouse K, Tang X, McLaughlin SA, Moreno-Aspitia A, Schweitzer A, Lu Y, Hubbard J, Northfelt DW, Gray RJ, Hunt K, Conners AL, Suman VJ, Kalari KR, Ingle JN, Lou Z, Visscher DW, Weinshilboum R, Boughey JC, Goetz MP, Wang L. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study. Breast Cancer Res. 2017 Dec 6; 19 (1):130 Epub 2017 Dec 06
    View PubMed
  15. O'Connor MK, Morrow MMB, Hunt KN, Boughey JC, Wahner-Roedler DL, Conners AL, Rhodes DJ, Hruska CB. Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer. EJNMMI Res. 2017 Dec; 7 (1):5 Epub 2017 Jan 14
    View PubMed
  16. Knight JA, Hunt KN, Carter J. Nodular fasciitis of the breast in an elderly woman. Radiol Case Rep. 2017 Dec; 12 (4):642-644 Epub 2017 Aug 12
    View PubMed
  17. Goetz MP, Kalari KR, Suman VJ, Moyer AM, Yu J, Visscher DW, Dockter TJ, Vedell PT, Sinnwell JP, Tang X, Thompson KJ, McLaughlin SA, Moreno-Aspitia A, Copland JA, Northfelt DW, Gray RJ, Hunt K, Conners A, Sicotte H, Eckel-Passow JE, Kocher JP, Ingle JN, Ellingson MS, McDonough M, Wieben ED, Weinshilboum R, Wang L, Boughey JC. Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer. J Natl Cancer Inst. 2017 Jul 1; 109 (7)
    View PubMed
  18. Jethwa KR, Kahila MM, Hunt KN, Brown LC, Corbin KS, Park SS, Yan ES, Boughey JC, Mutter RW. Delineation of Internal Mammary Nodal Target Volumes in Breast Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Mar 15; 97 (4):762-769 Epub 2016 Nov 27
    View PubMed
  19. O'Connor MK, Morrow MM, Tran T, Hruska CB, Conners AL, Hunt KN. Technical Note: Development of a combined molecular breast imagingultrasound system for diagnostic evaluation of MBI-detected lesions. Med Phys. 2017 Feb; 44: (2)451-459.
    View PubMed
  20. Rhodes DJ, Hruska CB, Conners AL, Hunt KN, O'Connor MK. Benefit-to-Radiation Risk for Breast Screening Tests Is a Flawed Concept. Radiology 2016 Dec; 281 (3):978-980
    View PubMed
  21. Long Z, Conners AL, Hunt KN, Hruska CB, O'Connor MK. Performance characteristics of dedicated molecular breast imaging systems at low doses. Med Phys. 2016 Jun; 43: (6)3062-3070.
    View PubMed
  22. Hruska CB, Scott CG, Conners AL, Whaley DH, Rhodes DJ, Carter RE, O'Connor MK, Hunt KN, Brandt KR, Vachon CM. Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study. Breast Cancer Res. 2016 Apr 26; 18 (1):42
    View PubMed
  23. Conners AL, Jones KN, Hruska CB, Geske JR, Boughey JC, Rhodes DJ. Direct-Conversion Molecular Breast Imaging of Invasive Breast Cancer: Imaging Features, Extent of Invasive Disease, and Comparison Between Invasive Ductal and Lobular Histology. AJR Am J Roentgenol. 2015 Sep; 205(3):W374-81.
    View PubMed
  24. Ellingson MS, Hart SN, Kalari KR, Suman V, Schahl KA, Dockter TJ, Felten SJ, Sinnwell JP, Thompson KJ, Tang X, Vedell PT, Barman P, Sicotte H, Eckel-Passow JE, Northfelt DW, Gray RJ, McLaughlin SA, Moreno-Aspitia A, Ingle JN, Moyer AM, Visscher DW, Jones K, Conners A, McDonough M, Wieben ED, Wang L, Weinshilboum R, Boughey JC, Goetz MP. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat. 2015 Sep; 153 (2):435-43 Epub 2015 Aug 22
    View PubMed
  25. Hruska CB, Conners AL, Jones KN, O'Connor MK, Moriarty JP, Boughey JC, Rhodes DJ. Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts. AJR Am J Roentgenol. 2015 Jun; 204 (6):1345-53
    View PubMed
  26. Hruska CB, Rhodes DJ, Conners AL, Jones KN, Carter RE, Lingineni RK, Vachon CM. Background parenchymal uptake during molecular breast imaging and associated clinical factors. AJR Am J Roentgenol. 2015 Mar; 204 (3):W363-70
    View PubMed
  27. O'Connor MK, Hruska CB, Tran TD, Swanson T, Conners AL, Jones K, Rhodes DJ. Factors influencing the uptake of 99mTc-sestamibi in breast tissue on molecular breast imaging. J Nucl Med Technol. 2015 Mar; 43(1):13-20. Epub 2015 Jan 22.
    View PubMed
  28. Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, Toledano AY, O'Connor MK. Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol. 2015 Feb; 204 (2):241-51
    View PubMed
  29. Glazebrook KN, Zingula S, Jones KN, Fazzio RT. Breast imaging findings in haematological malignancies. Insights Imaging. 2014 Dec; 5 (6):715-22 Epub 2014 Aug 07
    View PubMed
  30. Hruska CB, Conners AL, Jones KN, Weinmann AL, Lingineni RK, Carter RE, Rhodes DJ, O'Connor MK. Half-time Tc-99m sestamibi imaging with a direct conversion molecular breast imaging system. EJNMMI Res. 2014 Jan 15; 4 (1):5
    View PubMed
  31. Mitchell D, Hruska CB, Boughey JC, Wahner-Roedler DL, Jones KN, Tortorelli C, Conners AL, O'Connor MK. 99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer. Clin Nucl Med. 2013 Dec; 38 (12):949-56
    View PubMed
  32. Jones KN, Magut M, Henrichsen TL, Boughey JC, Reynolds C, Glazebrook KN. Pure lobular carcinoma of the breast presenting as a hyperechoic mass: incidence and imaging characteristics. AJR Am J Roentgenol. 2013 Nov; 201(5):W765-9.
    View PubMed
  33. Hieken TJ, Trull BC, Boughey JC, Jones KN, Reynolds CA, Shah SS, Glazebrook KN. Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. Surgery. 2013 Oct; 154(4):831-8; discussion 838-40.
    View PubMed
  34. Torstenson T, Shah-Khan MG, Hoskin TL, Morton MJ, Adamczyk DL, Jones KN, Case J, Chartier S, Boughey JC. Novel factors to improve prediction of nodal positivity in patients with clinical T1/T2 breast cancers. Ann Surg Oncol. 2013 Oct; 20(10):3286-93. Epub 2013 Jul 12.
    View PubMed
  35. Hieken TJ, Boughey JC, Jones KN, Shah SS, Glazebrook KN. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol. 2013 Oct; 20(10):3199-204. Epub 2013 Jul 12.
    View PubMed
  36. Swapp RE, Glazebrook KN, Jones KN, Brandts HM, Reynolds C, Visscher DW, Hieken TJ. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013 Jun; 20: (6)1900-5.
    View PubMed
  37. Jones KN, Pruthi S, Boughey JC, Simmons PS. Management of adolescent breast masses. J Surg Radiol. 2013 Apr 1; 4(2):59-63.
  38. Jones KN, Guimaraes LS, Reynolds CA, Ghosh K, Degnim AC, Glazebrook KN. Invasive micropapillary carcinoma of the breast: imaging features with clinical and pathologic correlation. AJR Am J Roentgenol. 2013 Mar; 200(3):689-95.
    View PubMed
  39. Jones KN. Imaging of the adolescent breast. Semin Plast Surg. 2013 Feb; 27 (1):29-35
    View PubMed
  40. Pruthi S, Jones KN. Nonsurgical management of fibroadenoma and virginal breast hypertrophy. Semin Plast Surg. 2013 Feb; 27 (1):62-6
    View PubMed
  41. Ansari B, Morton MJ, Adamczyk DL, Jones KN, Brodt JK, Degnim AC, Jakub JW, Lohse CM, Boughey JC. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases. Ann Surg Oncol. 2011 Oct; 18(11):3174-80. Epub 2011 Aug 23.
    View PubMed
  42. Glazebrook KN, Jones KN, Dilaveri CA, Perry K, Reynolds C. Imaging features of carcinoid tumors metastatic to the breast. Cancer Imaging. 2011 Jun 29; 11:109-15 Epub 2011 June 29
    View PubMed
  43. Jones KN, Glazebrook KN, Reynolds C. Pseudoangiomatous stromal hyperplasia: imaging findings with pathologic and clinical correlation. AJR Am J Roentgenol. 2010 Oct; 195(4):1036-42.
    View PubMed
  44. Jones K, Subramaniam RM, Durnick DK, Peller PJ. F-18-FDG-PET/CT imaging of small cell carcinoma of the colon. Clin Nucl Med. 2008 Sep; 33: (9)645-6.
    View PubMed
PST-20226315